Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 7/2006

01-07-2006

Specific Gene-Expression Profiles of Noncancerous Liver Tissue Predict the Risk for Multicentric Occurrence of Hepatocellular Carcinoma in Hepatitis C Virus–Positive Patients

Authors: Masahiro Okamoto, MD, Tohru Utsunomiya, MD, Shigeki Wakiyama, MD, Masaji Hashimoto, MD, Kengo Fukuzawa, MD, Takahiro Ezaki, MD, Taizo Hanai, MD, Hiroshi Inoue, MD, Masaki Mori, MD

Published in: Annals of Surgical Oncology | Issue 7/2006

Login to get access

Abstract

Background

Hepatitis C virus (HCV) infection produces chronic hepatitis, cirrhosis, and, ultimately, hepatocellular carcinoma (HCC). A molecular analysis of the damaged liver tissues infected with HCV may identify specific gene-expression profiles associated with a risk for liver carcinogenesis.

Methods

Forty patients with HCV-positive HCC were classified into two groups: single nodular HCC group (n = 28) and multicentric HCC group (n = 12). Using a complementary DNA microarray, we compared the gene-expression patterns of the noncancerous liver tissue specimens between the two groups. We also identified the differentially expressed genes related to multicentric recurrence in the liver remnant. We then evaluated whether a specific gene-expression profile can accurately estimate the risk for multicentric hepatocarcinogenesis.

Results

We selected the 230 differentially expressed genes in the multicentric HCC group. A hierarchical clustering analysis identified a cluster that might be closely associated with the multicentric occurrence of HCC. On the basis of the gene-expression profiling of the 36 genes commonly associated with both multicentric HCC and multicentric recurrence, we created a scoring system to estimate the risk for multicentric hepatocarcinogenesis. The prediction score of patients in the multicentric HCC group with multicentric recurrence (19.9 ± 9.2) was significantly higher (P < .05) than that in the single nodular HCC group without multicentric recurrence (−1.8 ± 12.7).

Conclusions

Specific gene-expression signatures in noncancerous liver tissue may help to accurately predict the risk for developing HCC.
Literature
1.
El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745–50PubMedCrossRef
2.
Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797–801PubMedCrossRef
3.
Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994;35:828–32PubMed
4.
Tarao K, Rino Y, Ohkawa S, et al. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 1999;86:589–95PubMedCrossRef
5.
Utsunomiya T, Matsumata T, Adachi E, et al. Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma. Hepatology 1992;16:694–701PubMed
6.
Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996;111:720–6PubMedCrossRef
7.
Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500–7PubMedCrossRef
8.
Takenaka K, Adachi E, Nishizaki T, et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology 1994;19:889–94PubMedCrossRef
9.
Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997;25:87–92PubMed
10.
Iizuka N, Oka M, Yamada Okabe H, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003;361:923–9PubMedCrossRef
11.
Kurokawa Y, Matoba R, Takemasa I, et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol 2004;41:284–91PubMedCrossRef
12.
Kim JW, Ye Q, Forgues M, et al. Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 2004;39:518–27PubMedCrossRef
13.
Liver Cancer Study Group of Japan. 2000. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 4th ed. Tokyo: Kanahara Shuppan, p 32–3
14.
Ueno S, Aoki D, Maeda T, et al. Preoperative assessment of multicentric occurrence in synchronous small and multiple hepatocellular carcinoma based on image-patterns and histological grading of non-cancerous region. Hepatol Res 2004;29:24–30PubMedCrossRef
15.
Utsunomiya T, Shimada M, Taguchi KI, et al. Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma. J Am Coll Surg 2000;190:331–5PubMedCrossRef
16.
Nishida K, Mine S, Utsunomiya T, et al. Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray. Cancer Res 2005;65:401–9PubMed
17.
Utsunomiya T, Okamoto M, Hashimoto M, et al. A gene-expression signature can quantify the degree of hepatic fibrosis in the rat. J Hepatol 2004;41:399–406PubMedCrossRef
18.
Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863–8PubMedCrossRef
19.
Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nat Genet 2001;29:365–71PubMedCrossRef
20.
Colombat M, Paradis V, Bieche I, et al. Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis. J Pathol 2003;201:260–7PubMedCrossRef
21.
Anders RA, Yerian LM, Tretiakova M, et al. cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am J Pathol 2003;162:991–1000PubMed
22.
Greer P, Haigh J, Mbamalu G, et al. The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol Cell Biol 1994;14:6755–63PubMed
23.
Orlovsky K, Theodor L, Malovani H, et al. Gamma interferon down-regulates Fer and induces its association with inactive Stat3 in colon carcinoma cells. Oncogene 2002;21:4997–5001PubMedCrossRef
24.
Larsson N, Segerman B, Howell B, et al. Op18/stathmin mediates multiple region-specific tubulin and microtubule-regulating activities. J Cell Biol 1999;146:1289–302PubMedCrossRef
25.
Neben K, Korshunov A, Benner A, et al. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res 2004;64:3103–11PubMedCrossRef
26.
Vauthey JN, Walsh GL, Vlastos G, et al. Importance of field cancerisation in clinical oncology. Lancet Oncol 2000;1:15–6PubMedCrossRef
Metadata
Title
Specific Gene-Expression Profiles of Noncancerous Liver Tissue Predict the Risk for Multicentric Occurrence of Hepatocellular Carcinoma in Hepatitis C Virus–Positive Patients
Authors
Masahiro Okamoto, MD
Tohru Utsunomiya, MD
Shigeki Wakiyama, MD
Masaji Hashimoto, MD
Kengo Fukuzawa, MD
Takahiro Ezaki, MD
Taizo Hanai, MD
Hiroshi Inoue, MD
Masaki Mori, MD
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 7/2006
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2006.07.018

Other articles of this Issue 7/2006

Annals of Surgical Oncology 7/2006 Go to the issue

OriginalPaper

Invasive Squamous Cell Carcinoma of the Skin: Defining a High-Risk Group

OriginalPaper

Local Recurrences After Conservative Treatment of Ductal Carcinoma-In-Situ of the Breast Without Radiotherapy: The Effect of Age

OriginalPaper

Effects of Location and Extension of Portal Vein Tumor Thrombus on Long-Term Outcomes of Surgical Treatment for Hepatocellular Carcinoma

OriginalPaper

The Prognostic Importance of Sentinel Lymph Node Biopsy in Thin Melanoma

OriginalPaper

Initial Outcomes for Patients Treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the Breast

OriginalPaper

Surgical Outcomes of Noninvasive and Minimally Invasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas